Related Experiment Video
Updated: Sep 4, 2025
08:56
A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
11.0K
RNA N6-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness
Huarong Chen1,2, Yifei Wang3, Hao Su1,2
1Department of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
Frontiers in Cell and Developmental Biology
|July 21, 2022
Summary
N6-Methyladenosine (m6A) RNA modification regulates cell fate and is crucial in cancer. This review explores how m6A impacts cellular reprogramming and cancer stemness.
Area of Science:
- Molecular Biology
- Epigenetics
- RNA Biology
Background:
- N6-Methyladenosine (m6A) is the most prevalent epitranscriptomic mark on eukaryotic messenger RNA.
- m6A is crucial for posttranscriptional RNA regulation, affecting splicing, transport, degradation, and translation.
- The dynamic m6A landscape is controlled by writers, readers, and erasers.
Purpose of the Study:
- To review the role of m6A modification in cellular reprogramming.
- To elucidate the connection between m6A regulators and cancer stemness properties.
- To highlight the implications of m6A dysregulation in cancer development.
Main Methods:
- Literature review of recent studies on m6A modification.
- Analysis of the functional interplay between m6A regulators and cell fate.
- Integration of data on m6A's role in cancer stemness.
Main Results:
- m6A regulators significantly influence cell fate transitions by altering biological processes like growth and differentiation.
- Aberrant m6A modification is strongly associated with various diseases, especially cancer.
- Perturbation of m6A pathways impacts key cellular functions relevant to stemness.
Conclusions:
- m6A modification is a critical determinant of cellular reprogramming.
- Dysregulation of m6A contributes to the development and maintenance of cancer stemness.
- Targeting m6A pathways may offer novel therapeutic strategies for cancer treatment.
Related Concept Videos
01:24Methods of Nuclear Reprogramming
1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K
01:29Somatic to iPS Cell Reprogramming
2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
01:14Introduction to Nuclear Reprogramming
2.0K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.0K
01:37Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
02:40Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
01:32Chromatin Modification in iPS Cells
1.9K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.9K